TocilizumabV1, Main, Exploration, indexHead, Title.i

Index : Titre (en)

Liste des classifications (clusters par fréquence et par distance de cosinus):

Les termes de plus forte occurence

2331	arthritis
1920	rheumatoid
1594	tocilizumab
1457	patients
1027	treatment
904	disease
549	therapy
515	clinical
460	interleukin
445	cell
438	anti
382	receptor
346	review
330	systemic
315	biologic
310	associated
302	patient
300	juvenile
299	idiopathic
299	efficacy
293	response
291	treated
287	analysis
279	case
276	syndrome
267	safety
240	arteritis
236	biological
233	inflammatory
229	diseases
218	antibody
217	therapeutic
209	onset
208	cells
205	refractory
197	after
196	tnf
193	new
192	drugs
188	report
187	results
181	drug
180	biologics
178	management
176	induced
176	factor
168	adult
167	covid
167	agents
162	activity
161	rheumatic
161	fri
160	risk
159	trial
153	still
152	thu
150	early
145	cancer
144	therapies
143	giant
140	effectiveness
138	systematic
138	remission
137	methotrexate
135	inhibitors
134	literature
131	severe
129	cohort
128	data
127	effects
127	effect
126	sat
126	necrosis
126	modifying
125	rituximab
121	tumor
121	role
121	abatacept
118	blockade
116	non
115	cytokine
114	phase
114	immune
114	during
113	inhibition
112	castleman
111	acute
110	inflammation
109	vasculitis
109	human
107	levels
106	takayasu
106	novel
106	infection
105	bone
104	term
104	related
104	meta
104	antibodies
103	chronic
102	autoimmune
101	long
101	inhibitor
99	serum
99	sclerosis
99	controlled
98	active
96	successful
96	lung
95	trials
94	potential
94	large
93	year
92	monotherapy
92	antirheumatic
91	monoclonal
89	practice
89	comparison
88	rheumatology
87	evaluation
86	factors
86	experience
84	real
84	expression
83	retrospective
82	randomized
82	outcomes
82	inadequate
81	update
80	first
78	versus
78	subcutaneous
78	progression
77	diagnosis
77	children
76	uveitis
76	lupus
75	single
75	observational
75	joint
72	registry
72	life
72	development
72	antigen
71	targeting
71	receiving
71	mediated
71	combination
70	impact
70	assessment
69	model
68	targeted
67	signaling
67	comparative
67	advances
66	amyloidosis
66	activation
65	target
65	chimeric
65	cases
64	pediatric
64	cardiovascular
64	adverse
63	label
63	etanercept
62	prospective
62	multicentric
61	pulmonary
61	high
61	dose
60	adalimumab
59	multicenter
58	radiographic
58	following
58	care
57	world
57	treatments
57	protein
57	oral
57	low
57	infliximab
57	hepatitis
57	center
57	car
57	association
56	vessel
56	polymyalgia
56	function
56	evidence
56	erythematosus
55	transplantation
55	rheumatica
55	recent
55	abstracts
54	type
54	open
54	interstitial
53	randomised
53	optica
53	neuromyelitis
53	changes
52	failure
51	years
51	responses
51	implications
51	health
51	cytokines
50	release
50	macrophage
49	stem
49	events
49	biomarkers
48	renal
48	multiple
48	but
47	virus
47	other
47	network
47	meeting
47	japan
47	intravenous
47	double
47	dmards
47	blood
46	spondylitis
46	line
46	infections
46	gene
46	characteristics
45	psoriatic
45	japanese
45	imaging
45	humanized
45	european
45	blind
45	ankylosing
45	alpha
44	tofacitinib
44	strategies
44	secondary
44	population
44	leukemia
44	immunotherapy
44	cost
43	treating
43	sustained
43	quality
43	pathogenesis
43	like
43	involvement
43	fever
43	against
42	who
42	rapid
42	production
42	pathway
42	outcome
42	administration
41	tissue
41	placebo
41	monitoring
40	tuberculosis
40	tafro
40	society
40	series
40	recommendations
40	future
40	follow
40	disorders
40	behçet
40	approach
39	tumour
39	survival
39	relapsing
39	different
39	complicated
38	without
38	synovial
38	switching
38	successfully
38	status
38	regulatory
38	primary
38	peripheral
38	moderate
38	damage
37	week
37	growth
36	index
36	eular
36	coronavirus
36	conventional
36	biomarker
36	annual
35	through
35	system
35	profile
35	influence
35	cutaneous
34	plasma
34	lymphoma
34	kidney
34	hypertension
34	effective
34	compared
33	treat
33	strategy
33	predictive
33	predict
33	positive
33	over
33	medicine
33	markers
33	hospital
33	complications
32	studies
32	resistant
32	molecular
32	level
32	glucocorticoid
32	features
32	emerging
31	via
31	under
31	synthetic
31	symptoms
31	stat
31	skin
31	score
31	research
31	reduction
31	rate
31	polychondritis
31	magnetic
31	control
31	carcinoma
30	targets
30	resonance
30	predictors
30	pilot
30	injury
30	improvement
30	dependent
29	spectrum
29	sarilumab
29	improves
29	group
29	discontinuation
29	challenges
28	than
28	serious
28	rates
28	pregnancy
28	pain
28	multicentre
28	multi
28	infectious
28	increased
28	due
28	concomitant
28	collagen
28	arterial
27	spondyloarthritis
27	sars
27	respiratory
27	resistance
27	reactive
27	options
27	mice
27	may
27	iii
27	french
27	does
27	derived
27	cov
26	three
26	specific
26	psoriasis
26	possible
26	pharmacokinetics
26	perspectives
26	inhibits
26	deficiency
25	utility
25	ultrasound
25	time
25	surgery
25	perspective
25	mechanisms
25	infusion
25	global
25	era
25	diagnostic
25	cross
25	beyond
25	anemia
25	agent
24	vitro
24	steroid
24	routine
24	mediterranean
24	manifestations
24	immunogenicity
24	heart
24	free
24	focus
24	fatigue
24	combined
24	checkpoint
24	body
24	amp
24	acr
23	transplant
23	survey
23	small
23	short
23	relapsed
23	polyarticular
23	pneumonia
23	overview
23	option
23	months
23	medical
23	mass
23	malignancies
23	macrophages
23	lymphoblastic
23	international
23	host
23	graves
23	graft
23	gastrointestinal
23	functional
23	critical
23	consensus
23	comprehensive
23	bowel
23	behcet
23	atherosclerosis
23	american
23	adults
22	vascular
22	tolerability
22	second
22	presentations
22	persistence
22	nationwide
22	national
22	month
22	metabolism
22	longitudinal
22	liver
22	jak
22	italian
22	insights
22	induces
22	fibrosis
22	dmard
22	database
22	coronary
22	congress
22	approaches
22	anakinra
21	weeks
21	understanding
21	tcz
21	signalling
21	sig
21	setting
21	reactions
21	reaction
21	promotes
21	post
21	peptide
21	pegol
21	patterns
21	old
21	naïve
21	joints
21	guidelines
21	established
21	disorder
21	common
21	childhood
21	certolizumab
21	baseline
21	aortic
21	action
20	suppresses
20	scleroderma
20	relationship
20	regulation
20	register
20	reduced
20	pro
20	prevalence
20	pandemic
20	myeloma
20	mri
20	marker

Manipulations en shell (Unix/Dilib)

HfdCat /Users/jacquesducloy/Documents/WicriRoot/Wicri/Sante/explor/Tocilizumab.storage/TocilizumabV1/Data/Main/Exploration/Title.i.hfd| SxmlCut idx/l | grep ...

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021

	Serveur d'exploration Tocilizumab - Exploration (Accueil) Index « Titre (en) » - tête de navigation
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration Tocilizumab - Exploration (Accueil)Index « Titre (en) » - tête de navigation

Index : Titre (en)

Les termes de plus forte occurence

Manipulations en shell (Unix/Dilib)

Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - tête de navigation